Today's Rundown Sanofi loses vaccines chief Loew to Ipsen amid global attention on its COVID-19 project [Sponsored] Salesforce proactively helps providers re-engage patients and reschedule elective procedures and services delayed by the COVID-19 crisis Microsoft's Lee details effort to get 'every single person' who has recovered from COVID-19 to donate plasma COVID-19 vaccine leaders talk up the need for partners, potential for a working vax by October Biopharma tracker: COVID vaccine leaders talk need for cooperation Teladoc exec: Why COVID-19 is proving a 'great equalizer' for mental health care Univ. of Maryland researchers develop 'naked eye' COVID-19 test Medicare Advantage, Part D plans face uncertain healthcare world under COVID-19 as they develop bids Amid pandemic, LabCorp's CRO unit Covance pens decentralized trials pact with Medable Moody's: The number of hospitals falling short of credit agreements expected to rise Quest Diagnostics' self-collection COVID-19 test kit gets FDA nod for emergency use FiercePharmaAsia—CanSino's COVID-19 vaccine data; Takeda's new Alunbrig nod; GSK-Samsung deal Featured Story | | | Friday, May 29, 2020 Sanofi's new CEO Paul Hudson has been making his mark in the company's C-suite, and his latest round of executive shuffling will impact the company's top vaccines job—even as it's prepping its GlaxoSmithKline-partnered COVID-19 candidate. Sanofi Pasteur chief David Loew is jumping ship to fellow French pharma Ipsen as CEO. |
|
|---|
|
| | | Monday, May 25, 2020 Many elective procedures were postponed due to COVID-19, but with the Salesforce Accelerate Elective Procedures solution, providers are able to re-engage patients and reschedule elective procedures. |
|
|---|
|
Top Stories Thursday, May 28, 2020 Blood plasma from patients who have recovered from COVID-19 holds promise as a potential treatment that could save lives. But, currently, there's a shortage of donors. In an interview with CNBC, Microsoft executive Peter Lee shares why the tech giant is working to help mobilize thousands of people to donate their blood plasma. Friday, May 29, 2020 Leaders from four of the biggest drugmakers in the world spoke about rising to the challenge of defeating the global pandemic as scaled-up trials and a potential approval peek over the horizon. Friday, May 29, 2020 The European Medicines Agency pledged to fast track studies of remdesivir to treat patients with COVID-19. Meanwhile, U.S. hospitals halted the use of hydroxychloroquine over safety concerns. Big Pharma vaccine makers met virtually at this year's international Federation of Pharmaceutical Manufacturers & Associations event, where they stressed that companies should work together to meet global vaccine needs. And while New Zealand reported only one active case of COVID-19 on Friday, outbreaks spiked in other countries. Friday, May 29, 2020 The COVID-19 pandemic is proving to be a “great equalizer” for behavioral health. And that's a trend an expert at Teladoc expect so see continue. Friday, May 29, 2020 Researchers at the University of Maryland are developing a simple, experimental diagnostic test for COVID-19 that could provide a visual result in 10 minutes, without any laboratory equipment. Friday, May 29, 2020 The COVID-19 pandemic has thrown a lot of uncertainty into healthcare, leaving Medicare Advantage and Part D plans trying to figure out their bids for 2021 plans. Friday, May 29, 2020 Digital clinical trials firm Medable is teaming up with Covance to allow the CRO to better navigate the COVID-19 disruption by using its virtual trial platform. Friday, May 29, 2020 With the sudden financial hardship—such as sharp declines in revenues and cash flow due to the cancellation of elective procedures because of the COVID-19 pandemic—a greater number of health systems may fall short of agreements tied to their borrowing compared to prior years, according to a recent report. Here's how they say hospital management should respond. Friday, May 29, 2020 Quest Diagnostics has received emergency use authorization for its self-collection COVID-19 test kit from the FDA. More than a half-million test kits to be available by end of June, with plans to make additional kits available on an ongoing basis. Friday, May 29, 2020 CanSino Biologics' COVID-19 vaccine yields positive phase 1 data. Takeda's Alunbrig wins FDA nod to treat newly diagnosed ALK-positive non-small cell lung cancer. GlaxoSmithKline adds biologics manufacturing capacity through a $231 million deal with Samsung Biologics. And more. |
